Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child. (Anonyme, 1998)

The Association of Pipe and Cigar Use With Cotinine Levels, Lung Function, and Airflow Obstruction: A Cross-sectional Study. (Rodriguez J, Jiang R, Johnson WC, Mackenzie BA, Smith LJ, Barr RG, 2010)

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. (Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, Burastero SE, Calori G, Benetti L, Bonazza P, Puccinelli P, Parmiani S, Bernardini R, Vierucci A, 2004)

Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. (Grembiale RD, Camporota L, Naty S, Tranfa CM, Djukanovic R, Marsico SA, 2000)

Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis. (Polosa R, Li Gotti F, Mangano G, Paolino G, Mastruzzo C, Vancheri C, Lisitano N, Crimi N, 2004)

Phase II Study of Amrubicin As Second-Line Therapy in Patients With Platinum-Refractory Small-Cell Lung Cancer. (Ettinger DS, Jotte R, Lorigan P, Gupta V, Garbo L, Alemany C, Conkling P, Spigel DR, Dudek AZ, Shah C, Salgia R, McNally R, Renschler MF, Oliver JW , 2010)

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10. (Butts CA, Ding K, Seymour L, Twumasi-Ankrah P, Graham B, Gandara D, Johnson DH, Kesler KA, Green M, Vincent M, Cormier Y, Goss G, Findlay B, Johnston M, Tsao M-S, Shepherd FA, 2010)

Impact of Environmental Tobacco Smoke on the Incidence of Mutations in Epidermal Growth Factor Receptor Gene in Never-Smoker Patients With Non–Small-Cell Lung Cancer. (Young Joo Lee, Byoung Chul Cho, Sun Ha Jee, Jin Wook Moon, Se Kyu Kim, Joon Chang, Kyung Young Chung, In Kyu Park, Sung Ho Choi, Joo-Hang Kim , 2010)

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy. (Krzakowski M, Ramlau R, Jassem J, Szczesna A, Zatloukal P, Von Pawel J, Sun X, Bennouna J, Santoro A, Biesma B, Delgado FM, Salhi Y, Vaissiere N, Hansen O, Tan E-H, Quoix E, Garrido P, Douillard JY , 2010)

  Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non–small-cell lung cancer (Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat MC, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon JP, 2010)

  Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. (Rutten FH, Zuithoff NP, Hak E, Grobbee DE, Hoes AW, 2010)

Effects of Inhaled Corticosteroids in Monotherapy or Combined with Long-acting beta2-agonists on Mortality among Patients with Chronic Obstructive Pulmonary Disease. (Cyr MC, Beauchesne MF, Lemiere C, Aaron SD, Blais L, 2010)